Skip to main content

Table 1 Analysis of the correlation between expression of miR-493 in primary NSCLC and its clinicopathological parameters

From: Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1)

clinicopathological rameters Total cases High expression Low expression P-value
Total patients 195 66 129  
Age (years)     0.365
 ≥60 117 36 81  
 <60 78 30 48  
Sex     0.450
 Male 135 42 93  
 Female 60 24 36  
Stage (NSCLC)     0.215
 I, II 114 51 63  
 III+ IV 81 15 66  
Histology     0.511
 SCC 75 30 45  
 Adenocarcinoma 84 24 60  
 Others 36 12 24  
Metastasis status     0.065
 Metastasis 84 15 69  
 No metastasis 111 51 60  
  1. NSCLC nonsmall-cell lung cancer, SCC squamous cell carcinoma